MedPath

Phase II study of S-1 for elderly patients with unresectable pancreatic cancer

Phase 2
Conditions
pancreatic cancer
Registration Number
JPRN-UMIN000006369
Lead Sponsor
Chigasaki Municipal Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
21
Inclusion Criteria

Not provided

Exclusion Criteria

1) severe diarrhea 2) require administration of flucytosine, phenytoin, and warfarin 3) severe pleural effusion, ascites fluid 4) active infection 5) active double cancer 6) active peptic ulcer 7) severe comorbidity (cardiovascular disease, renal disease, liver disease, Intestinal tract paralysis) 8) severe mental disorder 9) drug hypersensitivity 10) possibility of pregnancy or patient's hope to be pregnant 11) doctor's decision not to be registered to this study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Response rate
Secondary Outcome Measures
NameTimeMethod
Safety, overall survival, progression-free survival
© Copyright 2025. All Rights Reserved by MedPath